Efficacy News and Research

RSS
Researchers find a way to fine-tune the molecular assembly line that creates antibiotics

Researchers find a way to fine-tune the molecular assembly line that creates antibiotics

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine

PCR-based reverse genetic system helps analyze SARS-CoV-2 mutations

PCR-based reverse genetic system helps analyze SARS-CoV-2 mutations

New technology shows encouraging results for treating osteosarcoma

New technology shows encouraging results for treating osteosarcoma

High SARS-CoV-2 vaccine effectiveness in California, even with variants

High SARS-CoV-2 vaccine effectiveness in California, even with variants

Researchers receive $500,000 grant to test novel approach for restoring damaged muscles after injury

Researchers receive $500,000 grant to test novel approach for restoring damaged muscles after injury

Broadly cross-reactive antibody to SARS-CoV-2 RBD with robust resistance to mutational escape

Broadly cross-reactive antibody to SARS-CoV-2 RBD with robust resistance to mutational escape

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers work to develop dual antigen COVID-19 vaccine candidate

Researchers work to develop dual antigen COVID-19 vaccine candidate

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Screening for SARS-CoV-2 non-structural protein 14 inhibitors

Screening for SARS-CoV-2 non-structural protein 14 inhibitors

Previously approved drugs starting points for COVID-19 therapeutics

Previously approved drugs starting points for COVID-19 therapeutics

Analysis highlights the need for a more nuanced approach to COVID-19 vaccine prioritization

Analysis highlights the need for a more nuanced approach to COVID-19 vaccine prioritization

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers identify several novel SARS-CoV-2 inhibitors

Fauci thanks US health workers for sacrifices but admits PPE shortages drove up death toll

Fauci thanks US health workers for sacrifices but admits PPE shortages drove up death toll

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

Does natural infection with SARS-CoV-2 offer more protection than a vaccine against new variants?

Researchers reveal blood clot risk and anticoagulation benefits in discharged COVID-19 patients

Researchers reveal blood clot risk and anticoagulation benefits in discharged COVID-19 patients

Nemours receives grant to examine behavioral health intervention for adolescents with Type 1 diabetes

Nemours receives grant to examine behavioral health intervention for adolescents with Type 1 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.